Company intelligence / Profile preview

Beijing Health Guard Biotechnology Inc.

Beijing, Beijing, Chinapitchbook.com ↗
Ownership
Private
Development stage
Phase 3
01

Overview

Beijing Health Guard Biotechnology has a robust pipeline of prophylactic and therapeutic vaccines, with its most advanced product being a trivalent HPV vaccine expected to seek Chinese marketing approval by the end of this year. The company also has a nine-valent HPV vaccine in late-stage development, including clinical trials for men—the first such effort by a Chinese company. Additional programs include an mRNA-based HPV vaccine and preclinical candidates targeting RSV, VZV, hand-foot-and-mouth disease, norovirus, and COVID‑19. No products have been approved or commercialized as of May 2025[1][5][7].

Therapeutic areas
Women's HealthInfectious Diseases
Modalities
Recombinant protein vaccines (including E. coli-expressed)mRNA vaccines
Industry
Biotech
02

Drug pipeline

3 assets

KLWS-V502

3

2 more assets in the full pipeline.

Request access →
03

Partnerships

Liaoning Chengda Biotechnology Co., Ltd. for the fifteen-valent HPV program[1][5]

Beyond the preview

Go deeper on Beijing Health Guard Biotechnology Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Health Guard Biotechnology Inc..

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call